CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 100 target
Drug / intervention
High blood pressure treatmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00178490
NCT00178490Phase 1Completed

Neurocognitive Function in Children With Hypertension

University of Rochester·interventional·Posted Sep 15, 2005·Updated Jun 4, 2014

In Brief

A Phase 1 clinical trial evaluating High blood pressure treatment for Hypertension. Completed, enrolled 100 participants across 1 site.

Detailed Summary

High blood pressure, or hypertension, affects up to 10% of minority children and adolescents. Although complications of high blood pressure, such as stroke and heart attack, are uncommon in childhood, high blood pressure-related organ damage can occur at a young age. Studies with young adults have indicated that high blood pressure can affect the central nervous system, resulting in deficits in brain function. However, more research is necessary to confirm the association between neurocognitive deficits and high blood pressure in children and to determine if these deficits are reversible with treatment. This study will determine whether high blood pressure in children and adolescents has subtle effects on learning, attention, and concentration. The study will also determine the effect of an antihypertensive treatment plan, involving a combination of diet, weight loss, increased exercise, and if needed, blood pressure medication, on brain function in children and adolescents receiving treatment for high blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 15, 2005
Enrollment StartJan 1, 2005
Primary CompletionJun 1, 2009
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 20.8 years ago

Interventions

High blood pressure treatmentdrug

Participants who are identified as having high blood pressure will be given by a pediatric nephrologist a 12-month treatment plan for their high blood pressure. The treatment plan will include a combination of diet, weight loss, increased exercise, and if needed, blood pressure medication. Participants receiving medication treatment will be treated with a calcium channel blocker and/or ACE inhibitor.